Literature DB >> 25724256

Synovial chemokine expression and relationship with knee symptoms in patients with meniscal tears.

A Nair1, J Gan1, C Bush-Joseph2, N Verma2, M W Tetreault2, K Saha1, A Margulis3, L Fogg4, C R Scanzello5.   

Abstract

OBJECTIVE: In patients with knee OA, synovitis is associated with knee pain and symptoms. We previously identified synovial mRNA expression of a set of chemokines (CCL19, IL-8, CCL5, XCL-1, CCR7) associated with synovitis in patients with meniscal tears but without radiographic OA. CCL19 and CCR7 were also associated with knee symptoms. This study sought to validate expression of these chemokines and association with knee symptoms in more typical patients presenting for meniscal arthroscopy, many who have pre-existing OA.
DESIGN: Synovial fluid (SF) and biopsies were collected from patients undergoing meniscal arthroscopy. Synovial mRNA expression was measured using quantitative RT-PCR. The Knee Injury and Osteoarthritis Outcome Score (KOOS) was administered preoperatively. Regression analyses determined if associations between chemokine mRNA levels and KOOS scores were independent of other factors including radiographic OA. CCL19 in SF was measured by ELISA, and compared to patients with advanced knee OA and asymptomatic organ donors.
RESULTS: 90% of patients had intra-operative evidence of early cartilage degeneration. CCL19, IL-8, CCL5, XCL1, CCR7 transcripts were detected in all patients. Synovial CCL19 mRNA levels independently correlated with KOOS Activities of Daily Living (ADL) scores (95% CI [-8.071, -0.331], P = 0.036), indicating higher expression was associated with more knee-related dysfunction. SF CCL19 was detected in 7 of 10 patients, compared to 4 of 10 asymptomatic donors.
CONCLUSION: In typical patients presenting for meniscal arthroscopy, synovial CCL19 mRNA expression was associated with knee-related difficulty with ADL, independent of other factors including presence of radiographic knee OA.
Copyright © 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  KOOS; Knee disability; Osteoarthritis; Relative expression; Synovitis

Mesh:

Substances:

Year:  2015        PMID: 25724256      PMCID: PMC4470781          DOI: 10.1016/j.joca.2015.02.016

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  29 in total

Review 1.  Chemokines: a new classification system and their role in immunity.

Authors:  A Zlotnik; O Yoshie
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

2.  Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee.

Authors:  M T Hannan; D T Felson; T Pincus
Journal:  J Rheumatol       Date:  2000-06       Impact factor: 4.666

3.  The etiology of chondromalacia patellae. 1961.

Authors:  R E Outerbridge
Journal:  Clin Orthop Relat Res       Date:  2001-08       Impact factor: 4.176

4.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

5.  Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms.

Authors:  Carla R Scanzello; Brian McKeon; Bryan H Swaim; Edward DiCarlo; Eva U Asomugha; Veero Kanda; Anjali Nair; David M Lee; John C Richmond; Jeffrey N Katz; Mary K Crow; Steven R Goldring
Journal:  Arthritis Rheum       Date:  2011-02

6.  Relation of synovitis to knee pain using contrast-enhanced MRIs.

Authors:  K Baker; A Grainger; J Niu; M Clancy; A Guermazi; M Crema; L Hughes; J Buckwalter; A Wooley; M Nevitt; D T Felson
Journal:  Ann Rheum Dis       Date:  2010-05-14       Impact factor: 19.103

7.  Associations of anatomical measures from MRI with radiographically defined knee osteoarthritis score, pain, and physical functioning.

Authors:  Maryfran Sowers; Carrie A Karvonen-Gutierrez; Jon A Jacobson; Yebin Jiang; Matheos Yosef
Journal:  J Bone Joint Surg Am       Date:  2011-02-02       Impact factor: 5.284

8.  Diagnostic utility of cytokine biomarkers in the evaluation of acute knee pain.

Authors:  Jason M Cuellar; Gaetano J Scuderi; Vanessa Gabrovsky Cuellar; S Raymond Golish; David C Yeomans
Journal:  J Bone Joint Surg Am       Date:  2009-10       Impact factor: 5.284

9.  Meniscal tear in knees without surgery and the development of radiographic osteoarthritis among middle-aged and elderly persons: The Multicenter Osteoarthritis Study.

Authors:  Martin Englund; Ali Guermazi; Frank W Roemer; Piran Aliabadi; Mei Yang; Cora E Lewis; James Torner; Michael C Nevitt; Burton Sack; David T Felson
Journal:  Arthritis Rheum       Date:  2009-03

Review 10.  The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis.

Authors:  Ewa M Roos; L Stefan Lohmander
Journal:  Health Qual Life Outcomes       Date:  2003-11-03       Impact factor: 3.186

View more
  15 in total

1.  Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis.

Authors:  Mary Canavan; Alice M Walsh; Vipul Bhargava; Sarah M Wade; Trudy McGarry; Viviana Marzaioli; Barry Moran; Monika Biniecka; Hannah Convery; Siobhan Wade; Carl Orr; Ronan Mullan; Jean M Fletcher; Sunil Nagpal; Douglas J Veale; Ursula Fearon
Journal:  JCI Insight       Date:  2018-12-06

2.  Profibrotic Infrapatellar Fat Pad Remodeling Without M1 Macrophage Polarization Precedes Knee Osteoarthritis in Mice With Diet-Induced Obesity.

Authors:  Erika Barboza; Joanna Hudson; Wan-Pin Chang; Susan Kovats; Rheal A Towner; Robert Silasi-Mansat; Florea Lupu; Collin Kent; Timothy M Griffin
Journal:  Arthritis Rheumatol       Date:  2017-04-28       Impact factor: 10.995

3.  Evaluation of serum cytokines in cats with and without degenerative joint disease and associated pain.

Authors:  Margaret E Gruen; Kristen M Messenger; Andrea E Thomson; Emily H Griffith; Lauren A Aldrich; Shelly Vaden; B Duncan X Lascelles
Journal:  Vet Immunol Immunopathol       Date:  2016-12-16       Impact factor: 2.046

Review 4.  Chemokines and inflammation in osteoarthritis: Insights from patients and animal models.

Authors:  Carla R Scanzello
Journal:  J Orthop Res       Date:  2017-03-08       Impact factor: 3.494

5.  CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.

Authors:  Harini Raghu; Christin M Lepus; Qian Wang; Heidi H Wong; Nithya Lingampalli; Francesca Oliviero; Leonardo Punzi; Nicholas J Giori; Stuart B Goodman; Constance R Chu; Jeremy B Sokolove; William H Robinson
Journal:  Ann Rheum Dis       Date:  2016-12-13       Impact factor: 19.103

Review 6.  Peripheral Mechanisms Contributing to Osteoarthritis Pain.

Authors:  Delfien Syx; Phuong B Tran; Rachel E Miller; Anne-Marie Malfait
Journal:  Curr Rheumatol Rep       Date:  2018-02-26       Impact factor: 4.592

7.  Chemokine receptor-7 (CCR7) deficiency leads to delayed development of joint damage and functional deficits in a murine model of osteoarthritis.

Authors:  Nisha Sambamurthy; Vu Nguyen; Ryan Smalley; Rui Xiao; Kurt Hankenson; Justin Gan; Rachel E Miller; Anne-Marie Malfait; George R Dodge; Carla R Scanzello
Journal:  J Orthop Res       Date:  2017-08-29       Impact factor: 3.494

Review 8.  The innate immune response as a mediator of osteoarthritis pain.

Authors:  R J Miller; A-M Malfait; R E Miller
Journal:  Osteoarthritis Cartilage       Date:  2019-12-17       Impact factor: 6.576

9.  Combined bioinformatics analysis reveals gene expression and DNA methylation patterns in osteoarthritis.

Authors:  Delei Song; Wei Qi; Ming Lv; Chun Yuan; Kangsong Tian; Feng Zhang
Journal:  Mol Med Rep       Date:  2018-04-12       Impact factor: 2.952

10.  Nerve Growth Factor Enhances Tooth Mechanical Hyperalgesia Through C-C Chemokine Ligand 19 in Rats.

Authors:  Rui Guo; Yiyin Chen; Lu Liu; Jing Wen; Hong Yang; Yafen Zhu; Meiya Gao; Hengyan Liang; Wenli Lai; Hu Long
Journal:  Front Neurol       Date:  2021-06-01       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.